Drug
Neuroaid clinical trials
Also written MLC901 and MLC601.
- studies test it
- 11
- open now
- 3
- in phase 3
- 2
- first study started
- 2007
Keep track of what changes. Save the Neuroaid studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
11 studies that test it; most in 2026 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 2
- 4
- Phase 3
- 2
- Phase 4
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 7
Moleac Pte Ltd. (3) · Shahid Beheshti University of Medical Sciences (2) · National University Hospital, Singapore (2) · CHIMES Society (1) · Shahid Beheshti University (1) · EVD Pharmacy and Medical Company Limited (1) · University of the Philippines (1)
Studies
Open first, then newest update. How each study uses Neuroaid is read from its arms, and is right about nine times in ten.
Testing it · 11
- NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic StrokeRecruitingPhase 4EVD Pharmacy and Medical Company LimitedNCT07828210Written as MLC901
- Alzheimer's Disease THErapy With NEuroaid IINot yet recruitingPhase 3Moleac Pte Ltd.NCT07191028Written as MLC 901
- MLC901 in Moderate Traumatic Brain InjuryRecruitingPhase 4University of the PhilippinesNCT04766281Written as MLC901
- Spinal Cord Injury - Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiDCompletedPhase 4Moleac Pte Ltd.NCT02537899Written as NeuroAiD
- MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled TrialCompletedEarly Phase 1Shahid Beheshti University of Medical SciencesNCT05621590Written as MLC 901
- NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented SubjectsCompletedPhase 2National University Hospital, SingaporeNCT01847924Written as MLC901
- The Alzheimer's Disease THErapy With NEuroaid (ATHENE) StudyStatus unknownPhase 2National University Hospital, SingaporeNCT03038035Written as MLC901
- CHInese Medicine NeuroAid Efficacy on Stroke RecoveryCompletedPhase 3CHIMES SocietyNCT00554723Written as NeuroAid
- Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With RivastigmineCompletedPhase 2Shahid Beheshti University of Medical SciencesNCT01696123Written as MLC601
- Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After StrokeCompletedPhase 4Shahid Beheshti UniversityNCT01336153Written as MLC601
- Study of NeuroAid In Enhancing Recovery After StrokeCompletedPhase 2Moleac Pte Ltd.NCT00721825Written as Neuroaid
Codes
What other systems call Neuroaid · ClinicalTrials.gg INT005557
- MeSH (NLM) C546417NeuroaidOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C546417 | Neuroaid | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.